CBD attenuates amygdala response to negative emotional stimuli in individuals with alcohol use disorder: a randomized controlled trial
Negative affect is a key factor in Alcohol Use Disorder (AUD) associated with craving and relapse risk that is insufficiently treated by approved medications. Cannabidiol (CBD) has shown promising effects on negative affect, indicating its potential for addressing the neurocircuitry underlying negat...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
29 August 2025
|
| In: |
Psychopharmacology
|
| ISSN: | 1432-2072 |
| DOI: | 10.1007/s00213-025-06860-5 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00213-025-06860-5 |
| Verfasserangaben: | Marlen Pfisterer, Anton Teetzmann, Sina Vetter, Joscha Baeßler, Lena Schreckenberger, Judith Zaiser, Manuel Stenger, Patrick Bach |
| Zusammenfassung: | Negative affect is a key factor in Alcohol Use Disorder (AUD) associated with craving and relapse risk that is insufficiently treated by approved medications. Cannabidiol (CBD) has shown promising effects on negative affect, indicating its potential for addressing the neurocircuitry underlying negative affect in AUD. |
|---|---|
| Beschreibung: | Gesehen am 28.10.2025 |
| Beschreibung: | Online Resource |
| ISSN: | 1432-2072 |
| DOI: | 10.1007/s00213-025-06860-5 |